[A prevalent genetic variety of UDP-glycuronosyl transferase predicts high risk of irinotecan toxicity]. [electronic resource]
Producer: 20071011Description: 57-60 p. digitalISSN:- 0025-7680
- Antineoplastic Agents, Phytogenic -- adverse effects
- Camptothecin -- administration & dosage
- Carcinoma, Small Cell -- drug therapy
- Female
- Genetic Markers -- drug effects
- Genetic Variation -- genetics
- Glucuronosyltransferase -- drug effects
- Humans
- Irinotecan
- Lung Neoplasms -- drug therapy
- Middle Aged
- Neutropenia -- chemically induced
- Risk
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.